SEC Form 4/A · accession 0001209191-18-005576
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Marc A. Becker
Officer — CFO, PFO
Period of report
Jan 4, 2018
Accepted (ET)
Jan 26, 2018 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1 | $27.59 | Jan 4, 2018 | A | 100,000 | A | — | Jan 3, 2028 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option vests as to 25% of the original 100,000 shares on January 4, 2019 and then the remaining unvested shares vest in equal quarterly installments thereafter.
- F2On January 8, 2018, the reporting person mistakenly filed a Form 4 under the incorrect CIK code. This Form 4/A serves to correct that filing.